New Burlington Co. Covid Vaccination Sites; Camden drug dealer indicted for death of Medford “Customer”

Source: South Jersey Local News

Effective this week, the Burlington County Health Department will run four new Covid vaccine clinics on the following schedule:

• Mondays, from 2 to 6 p.m., at the Burlington County Emergency Services Training Center, 53 Academy Drive, Westampton (drive-thru clinic);

• Tuesdays, from 9 a.m. to 1 p.m. at the Palmyra Community Center, 30 West Broad, Palmyra;

• Wednesdays from noon to 4 p.m. at the Weimann Building, 400 Delanco Road, Edgewater Park;

• Thursdays from 3 to 7 p.m. at the Bordentown Township Senior Center, 3 Municipal Drive, Bordentown.

Appointments for the clinics can be made by online using the online registry at or by calling 1-855-568-0545. Walk-ins without appointments are also welcome.

A Burlington County grand jury has returned an indictment against Tareese Brown, 31, of Camden, which includes a charge of Strict Liability for Drug-Induced Death (First Degree).

The investigation began in September 2019 after officers from the Medford Township Police Department were called to Club House Lane in Camden for a report of an unresponsive 55-year-old female. An autopsy performed by the Burlington County Medical Examiner determined that the victim, Kimberly Bell, died of fentanyl and cocaine toxicity. The investigation revealed the drugs that caused the fatal overdose had been purchased from Brown.

The investigation also led to charges against Rashan Demby, 34, of Camden. Along with Mr. Brown, Mr. Demby was indicted for Possession of a Controlled Dangerous Substance (Third Degree); Distribution of a Controlled Dangerous Substance (Third Degree); and Conspiracy to Distribute a Controlled Dangerous Substance (Third Degree).

Brown and Demby have been lodged in the Burlington County Jail in Mount Holly since being arrested in February 2020.

For opioid addiction assistance, visit or call 844-REACHNJ.

Covid NJ: No Virus-Related NJ Hospital Deaths For First Time In 11 Months
Johnson & Johnson ends opioid business with $230 million settlement